أرسل هذا في رسالة قصيرة: Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

  _____    __   __   _    _      ___      ______  
 |__  //   \ \\/ // | \  / ||   / _ \\   /_   _// 
   / //     \ ` //  |  \/  ||  / //\ \\    | ||   
  / //__     | ||   | .  . || |  ___  ||  _| ||   
 /_____||    |_||   |_|\/|_|| |_||  |_|| /__//    
 `-----`     `-`'   `-`  `-`  `-`   `-`  `--`